| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/02/2011 | EP1248613B1 Clonidine preparations |
| 03/02/2011 | EP1064942B9 Sustained release preparation of a macrolide |
| 03/02/2011 | EP0800545B2 Targeted magnetically labeled molecular marker systems for the nmr imaging |
| 03/02/2011 | CN101983074A Use of pegylated igf-i variants for the treatment of neuromuscular disorders |
| 03/02/2011 | CN101983073A Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation |
| 03/02/2011 | CN101983064A Absorbent ingestible agents and associated methods of manufacture and use |
| 03/02/2011 | CN101983055A Method for production of orally rapidly disintegrating tablet comprising imidafenacin as active ingredient |
| 03/02/2011 | CN101983054A Orally rapidly disintegrating tablet comprising imidafenacin |
| 03/02/2011 | CN101982200A Rhizoma coptidis total alkaloids resin complexes, sustained-release preparation thereof and preparation method thereof |
| 03/02/2011 | CN101982199A Compositions containing acid-unstable physiologically active compounds and process for producing the same |
| 03/02/2011 | CN101982190A External cream for treating wind cold by utilizing percutaneous absorption technology |
| 03/02/2011 | CN101982176A Compound sodium selenite-vitamin E oral nano-emulsion preparation for livestock and preparation method thereof |
| 03/02/2011 | CN101982168A Quercetin nano-micelle preparation and preparation method thereof |
| 03/02/2011 | CN101278907B Coenzyme Q10 injection |
| 03/02/2011 | CN101185649B Levoleucovorin freeze-dried injection agent and preparation method and pharmaceutical use thereof |
| 03/02/2011 | CN101084889B Ginkgolide freezing-dried powder injection and preparation method thereof |
| 03/01/2011 | US7897757 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 03/01/2011 | US7897752 RNA interference mediated inhibition of telomerase gene expression using short interfering nucleic acid (siNA) |
| 03/01/2011 | US7897733 Rapamycin conjugates and antibodies |
| 03/01/2011 | US7897681 Hybrid PVC/wood-reinforcement nanocomposites and method of manufacture |
| 03/01/2011 | US7897647 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 03/01/2011 | US7897642 Compositions and methods for dry eye syndrome |
| 03/01/2011 | US7897586 Veterinary medicine; aqueous solution containing cyclodextrins |
| 03/01/2011 | US7897584 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 03/01/2011 | US7897563 Use of oligomers and polymers for drug solubilization, stabilization, and delivery |
| 03/01/2011 | US7897560 Plasma protein affinity tags |
| 03/01/2011 | US7897404 Chromatographically separated covalently coupled biomolecule and hydrophilic linker; kits; immunoassay |
| 03/01/2011 | US7897351 Peptides and antibodies to MUC 1 proteins |
| 03/01/2011 | US7897177 Particulate fibre composition |
| 03/01/2011 | US7897176 Hybrid composite dispersion; polycarbonateether block copolymer in aqueous solution |
| 03/01/2011 | US7897174 Formulation comprising bioactive agents and method of using same |
| 03/01/2011 | US7897173 Tramadol hydrochloride with such as diclofenac sodium; reduced water solubility |
| 03/01/2011 | US7897169 Improved bioavailability; dairy products, sauces; antioxidant activity in ameliorative/preventive efficacy in hypercholesterolemia, hyperlipemia and atherosclerosis |
| 03/01/2011 | US7897161 External medicine for treating dermatitis |
| 03/01/2011 | US7897160 Conjugated fatty acid based emulsion and methods for preparing and using same |
| 03/01/2011 | US7897158 Recombinant toxin fragments |
| 03/01/2011 | US7897154 Culture filtrate concentrate from Basidiomycetes; Parkinson's disease; diabetes |
| 03/01/2011 | US7897151 Anti-IgE vaccines |
| 03/01/2011 | CA2530001C Polymer |
| 03/01/2011 | CA2432441C Method for protecting a substance liable to oxidative deterioration |
| 03/01/2011 | CA2411660C Enzyme-cleavable prodrug compounds |
| 03/01/2011 | CA2348488C Novel agents and methods for treatment and diagnosis of ocular disorders |
| 02/25/2011 | CA2676583A1 Substances for reducing occurrence of major cardiac events in humans |
| 02/24/2011 | WO2011022652A1 Topical gels |
| 02/24/2011 | WO2011022467A2 Controlled-release formulations of anabaseine compounds and uses thereof |
| 02/24/2011 | WO2011022291A2 Photoregulated reversible hydrogels for delivery and releasing of drugs and other therapeutical reagents |
| 02/24/2011 | WO2011022056A2 PEPTIDE MODULATORS OF THE δPKC INTERACTION WITH THE D SUBUNIT OF F1FO ATP SYNTHASE/ATPASE AND USES THEREOF |
| 02/24/2011 | WO2011021804A2 Sensitive polymer capsule and method for preparing same |
| 02/24/2011 | WO2011021597A1 Quinoline derivative-containing pharmaceutical composition |
| 02/24/2011 | WO2011021594A1 Sustained drug delivery system |
| 02/24/2011 | WO2011021390A1 Bisphosphonic acid derivative and compound thereof labeled with radioactive metal nuclide |
| 02/24/2011 | WO2011020866A2 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | WO2011020783A2 Targeted immunoconjugates |
| 02/24/2011 | WO2011020526A1 Tabletting of erythritol and isomalt |
| 02/24/2011 | WO2011020294A1 Magnetic nanoparticles having novel core-shell structure and ph responsiveness, and use thereof |
| 02/24/2011 | WO2011020189A1 Forms of dexlansoprazole and processes for the preparation thereof |
| 02/24/2011 | WO2011020188A1 Peptide sequences and peptide-mediated sirna delivery |
| 02/24/2011 | WO2010129788A3 Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders |
| 02/24/2011 | WO2010114710A3 An artificial micro-gland |
| 02/24/2011 | WO2010111264A3 Rasagiline formulations |
| 02/24/2011 | WO2010104575A3 Omega-3 enriched fish oil-in-water parenteral nutrition emulsions |
| 02/24/2011 | WO2008020318A3 Non-viral compositions and methods for transfecting gut cells in vivo |
| 02/24/2011 | US20110046686 3-dimensional silk hydroxyapatite compositions |
| 02/24/2011 | US20110046606 Catheter injectable depot compositions and uses thereof |
| 02/24/2011 | US20110046242 Film Forming, Silicone Containing Compositions |
| 02/24/2011 | US20110046181 Short duration depot formulations |
| 02/24/2011 | US20110046099 Steroid hormone products and methods for preparing them |
| 02/24/2011 | US20110046095 Steroid hormone products and methods for preparing them |
| 02/24/2011 | US20110046072 Solid pharmaceutical formulation with delayed release |
| 02/24/2011 | US20110046004 Magnetic-nanoparticle conjugates and methods of use |
| 02/24/2011 | US20110045983 Gel composition |
| 02/24/2011 | US20110045107 Dietary Supplement and Method for the Treatment of Digestive Tract Ulcers in Equines |
| 02/24/2011 | US20110045087 Porous biocompatible polymer material and methods |
| 02/24/2011 | US20110045031 Use of Buckysome or Carbon Nanotube for Drug Delivery |
| 02/24/2011 | US20110045030 Crosslinkable polyisobutylene-based polymers and medical devices containing the same |
| 02/24/2011 | US20110045029 Oral formulation for delivery of poorly absorbed drugs |
| 02/24/2011 | US20110044967 Conjugates Comprising a Biodegradable Polymer and Uses Therefor |
| 02/24/2011 | US20110044922 Perfuming or flavouring microcapsules comprising an explosion suppressant |
| 02/24/2011 | DE102005062440B4 Proteinbasiertes Trägersystem zur Resistenzüberwindung von Tumorzellen Protein-based carrier system to overcome resistance of tumor cells |
| 02/24/2011 | CA2771790A1 Forms of dexlansoprazole and processes for the preparation thereof |
| 02/24/2011 | CA2771606A1 Methods of using cd44 fusion proteins to treat cancer |
| 02/24/2011 | CA2771403A1 Quinoline derivative-containing pharmaceutical composition |
| 02/24/2011 | CA2771348A1 Tabletting of erythritol and isomalt |
| 02/24/2011 | CA2771308A1 Topical gels |
| 02/24/2011 | CA2771207A1 Tablet manufacture |
| 02/24/2011 | CA2770762A1 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics |
| 02/24/2011 | CA2770609A1 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 02/24/2011 | CA2769619A1 Targeted immunoconjugates |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287234A1 Cellulose powder having excellent segregation preventive effect, and compositions thereof |
| 02/23/2011 | EP2287230A1 Docetaxel polymer derivative, method for producing same and use of same |
| 02/23/2011 | EP2287204A1 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes |
| 02/23/2011 | EP2287199A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287198A2 Anti-alpha V beta 6 antibodies |
| 02/23/2011 | EP2287193A1 Antibody molecules having specificity for human IL-1 beta |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2286847A1 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 02/23/2011 | EP2286845A1 Reagents methodsand kits for use in deactivating nucleic acids |